These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1334514)

  • 1. Treatment of resistant rheumatoid arthritis with minocycline: an open study.
    Langevitz P; Bank I; Zemer D; Book M; Pras M
    J Rheumatol; 1992 Oct; 19(10):1502-4. PubMed ID: 1334514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minocycline treatment for rheumatoid arthritis: an open dose finding study.
    Breedveld FC; Dijkmans BA; Mattie H
    J Rheumatol; 1990 Jan; 17(1):43-6. PubMed ID: 2313671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [An evaluation of efficacy of minocycline as an anti-rheumatic drug in patients with active and refractory rheumatoid arthritis].
    Kawanaka N; Yamamura M; Hashimoto H; Okamoto H; Morita Y; Kawashima M; Aita T; Okamoto A; Makino H
    Ryumachi; 1998 Dec; 38(6):801-9. PubMed ID: 10047718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early seropositive rheumatoid arthritis with minocycline: four-year followup of a double-blind, placebo-controlled trial.
    O'Dell JR; Paulsen G; Haire CE; Blakely K; Palmer W; Wees S; Eckhoff PJ; Klassen LW; Churchill M; Doud D; Weaver A; Moore GF
    Arthritis Rheum; 1999 Aug; 42(8):1691-5. PubMed ID: 10446869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minocycline in the treatment of rheumatoid arthritis: relationship of serum concentrations to efficacy.
    Kloppenburg M; Mattie H; Douwes N; Dijkmans BA; Breedveld FC
    J Rheumatol; 1995 Apr; 22(4):611-6. PubMed ID: 7791150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minocycline-induced hyperpigmentation in rheumatoid arthritis.
    Fay BT; Whiddon AP; Puumala S; Black NA; O'Dell JR; Mikuls TR
    J Clin Rheumatol; 2008 Feb; 14(1):17-20. PubMed ID: 18431092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The frequency and distribution of minocycline induced hyperpigmentation in a rheumatoid arthritis population.
    Roberts G; Capell HA
    J Rheumatol; 2006 Jul; 33(7):1254-7. PubMed ID: 16758512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides.
    Moreland LW; Morgan EE; Adamson TC; Fronek Z; Calabrese LH; Cash JM; Markenson JA; Matsumoto AK; Bathon J; Matteson EL; Uramoto KM; Weyand CM; Koopman WJ; Heck LW; Strand V; Diveley JP; Carlo DJ; Nardo CJ; Richieri SP; Brostoff SW
    Arthritis Rheum; 1998 Nov; 41(11):1919-29. PubMed ID: 9811045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose versus low dose fludarabine in the treatment of patients with severe refractory rheumatoid arthritis.
    Davis JC; Fessler BJ; Tassiulas IO; McInnes IB; Yarboro CH; Pillemer S; Wilder R; Fleisher TA; Klippel JH; Boumpas DT
    J Rheumatol; 1998 Sep; 25(9):1694-704. PubMed ID: 9733448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do minocycline and other tetracyclines have a place in rheumatology?
    Toussirot E; Despaux J; Wendling D
    Rev Rhum Engl Ed; 1997; 64(7-9):474-80. PubMed ID: 9338929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of infliximab therapy on gene expression levels of tumor necrosis factor alpha, tristetraprolin, T cell intracellular antigen 1, and Hu antigen R in patients with rheumatoid arthritis.
    Sugihara M; Tsutsumi A; Suzuki E; Wakamatsu E; Suzuki T; Ogishima H; Hayashi T; Chino Y; Ishii W; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
    Arthritis Rheum; 2007 Jul; 56(7):2160-9. PubMed ID: 17599736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy.
    Kavanaugh A; St Clair EW; McCune WJ; Braakman T; Lipsky P
    J Rheumatol; 2000 Apr; 27(4):841-50. PubMed ID: 10782805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Minocycline for the treatment of bronchiolitis obliterans associated with rheumatoid arthritis].
    Kase C; Okubo M; Yamasaki M; Yamada H; Suzuki Y; Hama N; Ichikawa Y; Sasaka K; Nakajima Y
    Ryumachi; 2001 Aug; 41(4):745-50. PubMed ID: 11577403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minocycline induced autoimmune disease in rheumatoid arthritis: a missed diagnosis?
    Marzo-Ortega H; Misbah S; Emery P
    J Rheumatol; 2001 Feb; 28(2):377-8. PubMed ID: 11246682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD20 therapy in patients with rheumatoid arthritis: predictors of response and B cell subset regeneration after repeated treatment.
    Roll P; Dörner T; Tony HP
    Arthritis Rheum; 2008 Jun; 58(6):1566-75. PubMed ID: 18512772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences of delayed therapy with second-line agents in rheumatoid arthritis: a 3 year followup on the hydroxychloroquine in early rheumatoid arthritis (HERA) study.
    Tsakonas E; Fitzgerald AA; Fitzcharles MA; Cividino A; Thorne JC; M'Seffar A; Joseph L; Bombardier C; Esdaile JM
    J Rheumatol; 2000 Mar; 27(3):623-9. PubMed ID: 10743799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pulsed dexamethasone therapy in early rheumatoid arthritis: a pilot study.
    Kroot EJ; Huisman AM; Van Zeben J; Wouters JM; Van Paassen HC
    Ann N Y Acad Sci; 2006 Jun; 1069():300-6. PubMed ID: 16855157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic T cell receptor clonotype changes in synovial tissue of patients with early rheumatoid arthritis: effects of treatment with cyclosporin A (Neoral).
    VanderBorght A; De Keyser F; Geusens P; De Backer M; Malaise M; Baeten D; Van den Bosch F; Veys EM; Raus J; Stinissen P
    J Rheumatol; 2002 Mar; 29(3):416-26. PubMed ID: 11908552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfasalazine in severe rheumatoid arthritis: a study to assess potential correlates of efficacy and toxicity.
    Martin L; Sitar DS; Chalmers IM; Hunter T
    J Rheumatol; 1985 Apr; 12(2):270-3. PubMed ID: 2863375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, randomized, double-blind, controlled trial of treatment of active rheumatoid arthritis with T-614 compared with methotrexate.
    Lu LJ; Bao CD; Dai M; Teng JL; Fan W; Du F; Yang NP; Zhao YH; Chen ZW; Xu JH; He PG; Wu HX; Tao Y; Zhang MJ; Han XH; Li XF; Gu JR; Li JH; Yu H
    Arthritis Rheum; 2009 Jul; 61(7):979-87. PubMed ID: 19565542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.